Mathematical modeling identifies Lck as a potential mediator for PD-1 induced inhibition of early TCR signaling.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30356330.
- Also identified by DOI 10.1371/journal.pone.0206232 and PMC identifier 6200280.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Programmed cell death-1 (PD-1) is an inhibitory immune checkpoint receptor that negatively regulates the functioning of T cell. Although the direct targets of PD-1 were not identified, its inhibitory action on the TCR signaling pathway was known much earlier. Recent experiments suggest that the PD-1 inhibits the TCR and CD28 signaling pathways at a very early stage ─ at the level of phosphorylation of the cytoplasmic domain of TCR and CD28 receptors. Here, we develop a mathematical model to investigate the influence of inhibitory effect of PD-1 on the activation of early TCR and CD28 signaling molecules. Proposed model recaptures several quantitative experimental observations of PD-1 mediated inhibition. Model simulations show that PD-1 imposes a net inhibitory effect on the Lck kinase. Further, the inhibitory effect of PD-1 on the activation of TCR signaling molecules such as Zap70 and SLP76 is significantly enhanced by the PD-1 mediated inhibition of Lck. These results suggest a critical role for Lck as a mediator for PD-1 induced inhibition of TCR signaling network. Multi parametric sensitivity analysis explores the effect of parameter uncertainty on model simulations.
Medical subject headings
- Algorithms
- Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
- Models, Immunological
- Programmed Cell Death 1 Receptor
- Receptors, Antigen, T-Cell
- Signal Transduction